These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1079422)

  • 1. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
    Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-antitrypsin and its deficiency.
    Kueppers F; Black LF
    Am Rev Respir Dis; 1974 Aug; 110(2):176-94. PubMed ID: 4212922
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha1-antitrypsin deficiency (second of two parts).
    Morse JO
    N Engl J Med; 1978 Nov; 299(20):1099-105. PubMed ID: 360065
    [No Abstract]   [Full Text] [Related]  

  • 7. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitrypsin deficiency and abnormal protease inhibitor phenotypes.
    Mittman C; Barbela T; Lieberman J
    Arch Environ Health; 1973 Sep; 27(3):201-6. PubMed ID: 4198687
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
    Kuhn C
    J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteases and protease inhibitors in chronic obstructive lung disease.
    Erikson S
    Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alpha 1-antitrypsin deficiency and chronic aspecific respiratory pathology (evaluation of the risk in the heterozygote state)].
    Marsico SA; Cantatore D; Gennarelli E
    Arch Monaldi; 1981; 36(3):119-30. PubMed ID: 6756332
    [No Abstract]   [Full Text] [Related]  

  • 15. [Editorial: The Pi system and alpha-1-antitrypsin deficiency states].
    Martin JP
    Nouv Presse Med; 1973 Oct; 2(36):2375-7. PubMed ID: 4594170
    [No Abstract]   [Full Text] [Related]  

  • 16. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease.
    Mittman C; Barbela T; Lieberman J
    J Occup Med; 1973 Jan; 15(1):33-8. PubMed ID: 4684725
    [No Abstract]   [Full Text] [Related]  

  • 18. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects.
    Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS
    Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteases and protease inhibitors; etiologic role in chronic obstructive emphysema].
    Kueppers F
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():700-2. PubMed ID: 6359127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.